Dimensional Fund Advisors LP increased its stake in shares of RTI Surgical, Inc. (NASDAQ:RTIX) by 2.0% during the first quarter, Holdings Channel reports. The fund owned 3,900,031 shares of the medical equipment provider’s stock after buying an additional 74,933 shares during the period. Dimensional Fund Advisors LP owned about 0.07% of RTI Surgical worth $15,600,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Nine Chapters Capital Management LLC boosted its stake in shares of RTI Surgical by 75.9% in the first quarter. Nine Chapters Capital Management LLC now owns 35,000 shares of the medical equipment provider’s stock valued at $140,000 after buying an additional 15,100 shares during the last quarter. American International Group Inc. boosted its stake in shares of RTI Surgical by 7.0% in the first quarter. American International Group Inc. now owns 35,371 shares of the medical equipment provider’s stock valued at $141,000 after buying an additional 2,327 shares during the last quarter. TFS Capital LLC boosted its stake in shares of RTI Surgical by 42.6% in the first quarter. TFS Capital LLC now owns 42,132 shares of the medical equipment provider’s stock valued at $169,000 after buying an additional 12,587 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in shares of RTI Surgical by 29.5% in the first quarter. Ameriprise Financial Inc. now owns 44,807 shares of the medical equipment provider’s stock valued at $180,000 after buying an additional 10,215 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its stake in shares of RTI Surgical by 176.0% in the first quarter. Russell Investments Group Ltd. now owns 78,055 shares of the medical equipment provider’s stock valued at $313,000 after buying an additional 49,777 shares during the last quarter. Institutional investors and hedge funds own 68.34% of the company’s stock.

Shares of RTI Surgical, Inc. (RTIX) traded up 1.515% during mid-day trading on Tuesday, hitting $5.025. The stock had a trading volume of 25,112 shares. The company’s 50 day moving average price is $5.55 and its 200 day moving average price is $4.53. The stock’s market cap is $296.65 million. RTI Surgical, Inc. has a 12-month low of $2.50 and a 12-month high of $6.00.

RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.02. RTI Surgical had a negative net margin of 6.53% and a positive return on equity of 2.07%. The firm had revenue of $72.10 million during the quarter, compared to analysts’ expectations of $70.25 million. RTI Surgical’s revenue for the quarter was up 6.7% on a year-over-year basis. Equities research analysts predict that RTI Surgical, Inc. will post $0.07 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Watch List News and is the property of of Watch List News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.watchlistnews.com/dimensional-fund-advisors-lp-has-15-60-million-position-in-rti-surgical-inc-rtix/1491701.html.

Several analysts have recently issued reports on the company. BidaskClub cut RTI Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, August 8th. ValuEngine upgraded RTI Surgical from a “sell” rating to a “hold” rating in a research note on Friday, June 2nd. TheStreet upgraded RTI Surgical from a “d+” rating to a “c-” rating in a research note on Friday, May 5th. Finally, Zacks Investment Research upgraded RTI Surgical from a “sell” rating to a “hold” rating in a research note on Thursday, May 11th.

In other RTI Surgical news, EVP John N. Varela purchased 12,000 shares of the firm’s stock in a transaction that occurred on Friday, August 11th. The stock was purchased at an average cost of $4.85 per share, with a total value of $58,200.00. Following the transaction, the executive vice president now owns 47,998 shares in the company, valued at $232,790.30. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Camille Farhat purchased 61,693 shares of the firm’s stock in a transaction that occurred on Thursday, May 18th. The shares were acquired at an average cost of $4.65 per share, with a total value of $286,872.45. The disclosure for this purchase can be found here. 4.90% of the stock is currently owned by corporate insiders.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Want to see what other hedge funds are holding RTIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RTI Surgical, Inc. (NASDAQ:RTIX).

Institutional Ownership by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.